| Issue Date | Title | Author(s) |
| 2021-07 | Alleviation of diabetic nephropathy by zinc oxide nanoparticles in streptozotocin-induced type 1 diabetes in rats. | Alomari, G; Al-Trad, B; Hamdan, S; Aljabali, AAA; Al Zoubi, MS; Al-Batanyeh, K; Qar, J; Eaton, GJ; Alkaraki, AK; Alshaer, W; Haifawi, S; Jemon, K; Chellappan, DK; Dua, K; Tambuwala, MM |
| 2021-01-01 | Chapter 28 Advancements on microparticles-based drug delivery systems for cancer therapy | Verma, D; Bhatia, A; Chopra, S; Dua, K; Prasher, P; Gupta, G; Tambuwala, MM; Chellappan, DK; Aljabali, AAA; Sharma, M; Kapoor, DN |
| 2021-01-01 | Chapter 15 Novel Controlled Release Pulmonary Drug Delivery Systems: Current updates and Challenges | Dhanjal, DS; Mehta, M; Chopra, C; Singh, R; Sharma, P; Chellappan, DK; Tambuwala, MM; Bakshi, HA; Aljabali, AAA; Gupta, G; Nammi, S; Prasher, P; Dua, K; Satija, S |
| - | Chronic Light-Distorted Glutamate-Cortisol Signaling, Behavioral and Histological Markers, and Induced Oxidative Stress and Dementia: An Amelioration by Melatonin | Sarena, P; Sharma, A; Urmera, MT; Tambuwala, MM; Aljabali, AAA; Chellappan, DK; Dua, K; Taliyan, R; Goyal, R |
| 2021-01-01 | Synthesis and anticancer properties of ‘Azole’ based chemotherapeutics as emerging chemical moieties: A comprehensive review | Prasher, P; Sharma, M; Zacconi, F; Gupta, G; Aljabali, AAA; Mishra, V; Tambuwala, MM; Kapoor, DN; Negi, P; Pinto, TDJA; Singh, I; Chellappan, DK; Dua, K |
| 2022-07 | Exosomal mediated signal transduction through artificial microRNA (amiRNA): A potential target for inhibition of SARS-CoV-2. | Vadivalagan, C; Shitut, A; Kamalakannan, S; Chen, R-M; Serrano-Aroca, Á; Mishra, V; Aljabali, AAA; Singh, SK; Chellappan, DK; Gupta, G; Dua, K; El-Tanani, M; Tambuwala, MM; Krishnan, A |
| 2021-01-01 | Nanosuspensions - An Update on Recent Patents, Methods of Preparation, and Evaluation Parameters. | Khanuja, HK; Awasthi, R; Mehta, M; Satija, S; Aljabali, AA; Tambuwala, MM; Chellappan, DK; Dua, K; Dureja, H |
| 2021 | Perfluorocarbons Therapeutics in Modern Cancer Nanotechnology for Hypoxiainduced Anti-tumor Therapy. | Satija, S; Sharma, P; Kaur, H; Dhanjal, DS; Chopra, RS; Khurana, N; Vyas, M; Sharma, N; Tambuwala, MM; Bakshi, HA; Charbe, NB; Zacconi, FC; Chellappan, DK; Dua, K; Mehta, M |
| 2021-01-01 | A potential MRI agent and an anticancer drug encapsulated within CPMV virus-like particles. | Aljabali, AAA; Alzoubi, L; Hamzat, Y; Alqudah, A; Obeid, MA; Al Zoubi, MS; Ennab, RM; Alshaer, W; Albatayneh, K; Al-Trad, B; Alqudah, DA; Chellappan, DK; Gupta, G; Tambuwala, MM; Kamal, D; Evans, DJ |
| - | Self-nanoemulsifying drug delivery system (SNEDDS) mediated improved oral bioavailability of thymoquinone: optimization, characterization, pharmacokinetic, and hepatotoxicity studies | Rathore, C; Hemrajani, C; Sharma, AK; Gupta, PK; Jha, NK; Aljabali, AAA; Gupta, G; Singh, SK; Yang, J-C; Dwivedi, RP; Dua, K; Chellappan, DK; Negi, P; Tambuwala, MM |
